Evidence map›Paper›PMID 19692330›Full record

ArticleThe Journal of biological chemistry2009

The 1.5-A structure of XplA-heme, an unusual cytochrome P450 heme domain that catalyzes reductive biotransformation of royal demolition explosive.

Federico Sabbadin, Rosamond Jackson, Kamran Haider, Girish Tampi, Johan P Turkenburg, Sam Hart, Neil C Bruce, Gideon Grogan

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Unusual properties of the cytochrome P450 superfamily.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2013
    Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Federico SabbadinYork Structural Biology Laboratory, Department of Biology, University of York, York YO10 5YW, United Kingdom; Centre for Novel Agricultural Products, Department of Biology, University of York, York YO10 5YW, United Kingdom.
Rosamond JacksonCentre for Novel Agricultural Products, Department of Biology, University of York, York YO10 5YW, United Kingdom.
Kamran HaiderYork Structural Biology Laboratory, Department of Biology, University of York, York YO10 5YW, United Kingdom.
Girish TampiCentre for Novel Agricultural Products, Department of Biology, University of York, York YO10 5YW, United Kingdom.
Johan P TurkenburgYork Structural Biology Laboratory, Department of Biology, University of York, York YO10 5YW, United Kingdom.
Sam HartYork Structural Biology Laboratory, Department of Biology, University of York, York YO10 5YW, United Kingdom.
Neil C BruceCentre for Novel Agricultural Products, Department of Biology, University of York, York YO10 5YW, United Kingdom.
Gideon GroganYork Structural Biology Laboratory, Department of Biology, University of York, York YO10 5YW, United Kingdom. Electronic address: grogan@ysbl.york.ac.uk.
University of York · GB

Funding

Biotechnology and Biological Sciences Research Council BB/E000576/1Medical Research Council G0500367
6 · The paper itself

Abstract

XplA is a cytochrome P450 of unique structural organization, consisting of a heme-domain that is C-terminally fused to its native flavodoxin redox partner. XplA, along with flavodoxin reductase XplB, has been shown to catalyze the breakdown of the nitramine explosive and pollutant hexahydro-1,3,5-trinitro-1,3,5-triazine (royal demolition explosive) by reductive denitration. The structure of the heme domain of XplA (XplA-heme) has been solved in two crystal forms: as a dimer in space group P2(1) to a resolution of 1.9 A and as a monomer in space group P2(1)2(1)2 to a resolution of 1.5 A, with the ligand imidazole bound at the heme iron. Although it shares the overall fold of cytochromes P450 of known structure, XplA-heme is unusual in that the kinked I-helix that traverses the distal face of the heme is broken by Met-394 and Ala-395 in place of the well conserved Asp/Glu plus Thr/Ser, important in oxidative P450s for the scission of the dioxygen bond prior to substrate oxygenation. The heme environment of XplA-heme is hydrophobic, featuring a cluster of three methionines above the heme, including Met-394. Imidazole was observed bound to the heme iron and is in close proximity to the side chain of Gln-438, which is situated over the distal face of the heme. Imidazole is also hydrogen-bonded to a water molecule that sits in place of the threonine side-chain hydroxyl exemplified by Thr-252 in Cyt-P450cam. Both Gln-438 --> Ala and Ala-395 --> Thr mutants of XplA-heme displayed markedly reduced activity compared with the wild type for royal demolition explosive degradation when combined with surrogate electron donors.

Indexed as

BiotransformationProtein Structure, TertiaryAmino Acid SequenceBinding SitesCrystallography, X-RayCytochrome P-450 Enzyme SystemExplosive AgentsHemeHumansIsoenzymesModels, MolecularMolecular Sequence DataMolecular StructureOxidation-ReductionSequence AlignmentTriazinescycloniteCytochrome P-450 Enzyme SystemExplosive AgentsHemeIsoenzymesTriazines

Identifiers

PMID19692330
PMCPMC2788895
OpenAlexW2101960365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.